Shandong Cancer Hospital and Institute: all 105 studies

Page 1 of 2. Open to participants first (38), then studies with results posted, then the rest; newest registration first within each.

• A Multicenter, Randomized, Controlled Phase III Clinical Trial on Adjuvant Intensified Therapy for Patients With Residual Disease After Neoadjuvant Treatment for Triple-negative Breast CancerNot yet recruitingNCT07869628Phase 3
• IMPT Versus IMRT for Diffuse Intrinsic Pontine GliomaNot yet recruitingNCT07869524Phase 3
• Clinical Evaluation of 177Lu-FAP-VG11 Injection in Patients With Fibroblast Activation Protein -Positive Advanced Solid TumoursRecruitingNCT07808177Early Phase 1
• Short-Course Radiotherapy Followed by CAPOX With or Without Iparomlimab and Tuvonralimab in pMMR/MSS Locally Advanced Rectal CancerRecruitingNCT07686640Phase 3
• SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic CancerRecruitingNCT07683221Phase 2
• Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic CancerRecruitingNCT07600268Phase 2
• Concordance Between Large Language Model and Multidisciplinary Team Recommendations in Rectal CancerRecruitingNCT07595107
• Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic CancerRecruitingNCT07408505Not applicable
• The Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2-Targeted TherapyRecruitingNCT07376174
• Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell CarcinomaRecruitingNCT07333274Phase 3
• Identification of HER2-Positive Breast Cancer Molecular Characterization and SubtypesNot yet recruitingNCT07187752Not applicable
• Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic CancerRecruitingNCT07173387Phase 2
• Early Screening Cohort Study of Multiple Gastrointestinal TumorsRecruitingNCT07106424
• Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast CancerNot yet recruitingNCT07093931Phase 4
• BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or OligometastasesRecruitingNCT07062055Phase 2
• Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT)RecruitingNCT07026422Phase 2
• SFRT and SCART in Radiotherapy for Bone Metastases With Soft TissueRecruitingNCT06987370Not applicable
• Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue SarcomaRecruitingNCT06980259Not applicable
• Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical CancerRecruitingNCT06942416Phase 2
• Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III TrialRecruitingNCT06850090Phase 3
• Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin InjuryRecruitingNCT06847555Phase 1/2
• Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)RecruitingNCT06844422Phase 1/2
• Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCCRecruitingNCT06841172Phase 3
• Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or AdolescentsRecruitingNCT06816771Phase 2
• Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast CancerRecruitingNCT06802757Phase 2
• Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.RecruitingNCT06778382Phase 2
• Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06714266Phase 2
• A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy.Not yet recruitingNCT06649448Not applicable
• Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial CarcinomaRecruitingNCT06532539Phase 2
• A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous CancerRecruitingNCT06398405Phase 2
• Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver MetastasesRecruitingNCT06356584Phase 2
• Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLCRecruitingNCT06241807Phase 2
• Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic CancerRecruitingNCT06050317Phase 2
• A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell LymphomaRecruitingNCT05933967Phase 2
• Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer PatientsRecruitingNCT05758571Phase 1/2
• Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line ChemoradiotherapyRecruitingNCT04829708Phase 3
• Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative ChemotherapyNot yet recruitingNCT03684863Phase 2
• Oral Green Tea Extract for Small Cell Lung CancerAvailableNCT01317953
• Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell CarcinomaCompletedNCT00815308Phase 2Results posted
• A Phase II Clinical Trial of Ivonescimab Plus Third-generation EGFR-TKIs in Advanced Non-small Cell Lung Cancer With Gradual or Potential Progression After EGFR-TKIs TreatmentActive, not recruitingNCT07669051Phase 2
• Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-AnalysisCompletedNCT07403370
• CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung CancerCompletedNCT07316309
• SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular CarcinomaSuspendedNCT07274774Phase 2
• Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility StudySuspendedNCT07173374Phase 1
• Study of of Oxygen Nebulized Inhalation EGCG in Cancer Patients With New Coronary PneumoniaCompletedNCT06924749Phase 2
• WASPE Sleep Adjustment for Children Aged 0-4 Years Undergoing Radiation TherapyCompletedNCT06443632Not applicable
• First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAICTerminatedNCT06370663Phase 2
• Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver CancerCompletedNCT06261047
• Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal CancerActive, not recruitingNCT06246344Phase 3
• Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma.Status unknownNCT05323890Phase 2
• A Phase I Study of IBI325 in Patients With Advanced Solid TumorStatus unknownNCT05246995Phase 1
• A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular CarcinomaActive, not recruitingNCT05185531Phase 1
• A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular CarcinomaCompletedNCT05099848Phase 2
• Patient Report Outcome and Oncological Safety -Oncoplastic and Conventional BCS CohortStatus unknownNCT05054777
• Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal CancerCompletedNCT05039983Phase 1
• A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLCStatus unknownNCT04982549Phase 2
• A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung CancerTerminatedNCT04958993Phase 1/2
• Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)Status unknownNCT04676997Phase 2
• Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain MetastasisStatus unknownNCT04639271Phase 2
• A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer PatientsStatus unknownNCT04619563Phase 2
• A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung CancerStatus unknownNCT04619537Phase 2
• Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBCStatus unknownNCT04609540
• Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast CancerStatus unknownNCT04568941Not applicable
• SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLCActive, not recruitingNCT04562337Phase 2
• A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line TreatmentStatus unknownNCT04560244Phase 2
• A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent GlioblastomaStatus unknownNCT04552977Phase 2
• Metabolomics Explores Biomarkers for Metastatic Breast CancerStatus unknownNCT04302415
• Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast CancerStatus unknownNCT04246502Phase 2
• Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast CancerStatus unknownNCT04143906Phase 2
• Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid TumorsStatus unknownNCT04110223
• Temperature and Injury in Radiotherapy Radiation Skin InjuryStatus unknownNCT04047823
• Clinical Study on the Treatment of Recurrent Glioblastoma With AnlotinibStatus unknownNCT04004975Phase 1/2
• Intraoperative Molecular Diagnosis of Sentinel Lymph Node In Breast Cancer PatientsStatus unknownNCT03937414Not applicable
• Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLCStatus unknownNCT03884192Phase 3
• Minimally Invasive Biopsy Predicting Breast pCR After NAC for Breast CancerStatus unknownNCT03789851Not applicable
• Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC PatientsStatus unknownNCT03672136Phase 2
• A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLCStatus unknownNCT03557411Phase 2
• Internal Mammary Sentinel Lymph Node Biopsy With Modified Injection TechniqueStatus unknownNCT03541278Not applicable
• Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC PatientsStatus unknownNCT03489616Not applicable
• Elective Simultaneous Modulated Accelerated Brain Radiation Therapy for NSCLCs With Limited Brain MetastasesStatus unknownNCT03414944Not applicable
• The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.CompletedNCT03384511Phase 4
• Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal MetastasisStatus unknownNCT03029065
• The Multi-center Validation Study of Internal Mammary Lymph Biopsy With Modified Injection Technique in Breast Cancer PatientsStatus unknownNCT03024463
• Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790MStatus unknownNCT02972333Phase 3
• Shandong Cancer Hospital Affiliated to Shandong UniversityStatus unknownNCT02958033Phase 3
• Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive PatientsStatus unknownNCT02793791Not applicable
• Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT02790190Phase 3
• A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCCTerminatedNCT02721576Phase 4
• A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCCCompletedNCT02721563Phase 4
• A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCCTerminatedNCT02721550Phase 4
• Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant RadiotherapyStatus unknownNCT02580279Phase 2
• Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial RadiotherapyStatus unknownNCT02577393Phase 2
• Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast CancerStatus unknownNCT02544243Phase 2
• A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell CarcinomaStatus unknownNCT02409186Phase 3
• Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT02195453Phase 4
• Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung CancerStatus unknownNCT02191059Phase 2
• A Explore Study of Bevacizumab Combined With Conventional Therapy in GlioblastomaStatus unknownNCT01939574Not applicable
• Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI ReconstructionStatus unknownNCT01917578Phase 3
• Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph NodeWithdrawnNCT01796444Phase 3
• Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -PositiveCompletedNCT01668914Phase 3

← Shandong Cancer Hospital and Institute overview and focus areas